Member of Farmavita.net is offering marketing authorisation transfer for dossier in European CTD format for Carboplatin, 10mg/ml as 50-150-450-600 ml, solution for injection.
Dossier is submitted in reference member state. License for use of Dossier is related to commitment of bulk vials purchase.
Carboplatin is classified as antineoplastc and immunomodulating medicine according ATC index.
Offer is valid subject to confirmation, country by country. Development of this pharmaceutical is carried out according to EU-requirements in country without patent protection or with Bolar-provisions. There will be no sales in those countries where this offer would constitute an infringement of third parties intellectual proprietary rights.
|Pharma licensing||Out-licensing (offer)|